Teneligliptin
- Generic Name
- Teneligliptin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C22H30N6OS
- CAS Number
- 760937-92-6
- Unique Ingredient Identifier
- 28ZHI4CF9C
- Background
Teneligliptin has been investigated for the treatment of Type 2 Diabetes Mellitus.
- Indication
用于2型糖尿病患者。
- Associated Conditions
- Type 2 Diabetes Mellitus
- Associated Therapies
- -
Long-term Safety Study of MP-513 as Monotherapy or in Combination With Sulfonylurea in Japanese Type 2 Diabetic Patients
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-12-11
- Last Posted Date
- 2015-08-20
- Lead Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Target Recruit Count
- 240
- Registration Number
- NCT02314637
- Locations
- 🇯🇵
Reserch site, Shikoku, Japan
Long-term Safety Study of MP-513 in Patients With Type 2 Diabetes
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-02-23
- Last Posted Date
- 2015-11-18
- Lead Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Target Recruit Count
- 462
- Registration Number
- NCT01301833
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath